VANI

Vivani Medical, Inc.

Healthcare
Biotechnology
$110M market cap

Forecast run · Sep 14, 2026Upside rank 917 of 3,136

Model Signal

ForecastQ Daily Probabilities

46.6%

53.2%

24.3%

Analyst Consensus

Recommendation2.00/5 Buy

Last price$1.27

Price target$4.00

Implied move+215.0%

Analysts2

ForecastQ Portfolios

VANI is not in any ForecastQ portfolio today. The model scores it with every run; the names it picked are in Portfolios.

Company Profile

Vivani Medical, Inc., a clinical-stage biopharmaceutical company, engages in the development of miniaturized and subdermal drug implants that treat chronic diseases. The company uses its NanoPortal implant technology to develop and potentially commercialize drug implant candidates, alone or in collaboration with pharmaceutical company partners, to address causes of poor clinical outcomes in the treatment of chronic diseases. Its pipeline includes NPM-139 for chronic weight management in patients who are obese or overweight; NPM-133 a semaglutide implant for the treatment of patients with type 2 diabetes; NPM-115, an exenatide implant candidate for chronic weight management in patients who are obese or overweight; and OKV-119, an exenatide implant for the treatment of obesity and diabetes in companion animals, including cats and dogs. The company is headquartered in Alameda, California.